Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
- PMID: 36347428
- PMCID: PMC9637020
- DOI: 10.1016/j.jinf.2022.11.001
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
Keywords: MPXV; Monkeypox; Orthopoxvirus; cidofovir; tecovirimat.
Conflict of interest statement
Conflicts of interests The authors declare no conflict of interest for the present study.
Figures
Comment on
-
Targeting F13 from monkeypox virus and variola virus by tecovirimat: Molecular simulation analysis.J Infect. 2022 Oct;85(4):e99-e101. doi: 10.1016/j.jinf.2022.07.001. Epub 2022 Jul 8. J Infect. 2022. PMID: 35810941 No abstract available.
References
-
- Li D, Liu Y, Li K, Zhang L. Targeting F13 from monkeypox virus and variola virus by tecovirimat: Molecular simulation analysis. J Infect. 2022;85:e99–e101. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
